Acute tubular injury causes dysregulation of cellular cholesterol transport proteins

American Journal of Pathology

Volumn 163, Issue 1, 2003, Pages 313-320

  Zager, Richard A ^a,c   Johnson, Ali C M ^a   Hanson, Sherry Y ^a   Shah, Vallabh O ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CELL PROTEIN; CHOLESTEROL ESTER; GLYCEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; PROTEIN ABCA 1; SCAVENGER RECEPTOR BI; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL SYNTHESIS; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; KIDNEY CORTEX; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE DAMAGE; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; RHABDOMYOLYSIS; UREA NITROGEN BLOOD LEVEL; UREMIA; WESTERN BLOTTING;

EID: 0038645852     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63655-3     Document Type: Article

References (38)

1. Zager RA, Johnson A: Renal cortical cholesterol accumulation is an integral component of the systemic stress response. Kidney Int 2001, 60:2299-2310
2. Zager RA, Burkhart KM, Johnson AC, Sacks BM: Increased proximal tubular cholesterol content: implications for cell injury and "acquired cytoresistance". Kidney Int 1999, 56:1788-1797
3. Zager RA: Plasma membrane cholesterol: a critical determinant of cellular energetics and tubular resistance to attack Kidney Int 2000, 58:193-205
4. Zager RA, Kalhorn TF: Changes in free and esterified cholesterol: hallmarks of acute renal tubular injury and acquired cytoresistance. Am J Pathol 2000, 157:1007-1016
5. Zager RA, Johnson A, Anderson K, Wright S: Cholesterol ester accumulation: an immediate consequence of acute in vivo ischemic renal injury. Kidney Int 2001, 59:1750-1761
6. Zager RA, Johnson A, Hanson S, dela Rosa V: Altered cholesterol localization and caveolin expression during the evolution of acute renal failure. Kidney Int 2002, 61:1674-1683
7. Zager RA, Andoh T, Bennett WM: Renal cholesterol accumulation: a durable response after acute and subacute renal insults. Am J Pathol 2001, 159:743-752
8. Zager RA, Shah VO, Shah HV, Zager PG, Johnson AC, Hanson S: The mevalonate pathway during acute tubular injury: selected determinants and consequences. Am J Pathol 2002, 161:681-692
9. Zager RA, Johnson ACM, Hanson SY: Sepsis syndrome stimulates proximal tubule cholesterol synthesis and suppresses the SR-B1 cholesterol transporter. Kidney Int 2003, 63:123-133
10. Honda N, Hishida A, Ikuma K, Yonemura K: Acquired resistance to acute renal failure. Kidney Int 1987, 31:1233-1238
11. Nath KA, Balla G, Verrcelloti J, Balla H, Jacob H, Levitt M, Rosenberg M: Induction of heme oxygenase is a rapid protective response in rhabdomyolysis in the rat. J Clin Invest 1992, 90:267-270
12. Leung N, Croatt AJ, Haggard JJ, Grande JP, Nath KA: Acute cholestatic liver disease protects against glycerol-induced acute renal failure in the rat. Kidney Int 2001, 60:1047-1057
13. Paller MS: Hemoglobin and myoglobin-induced acute renal failure: role of iron in nephrotoxicity. Am J Physiol 1998, 255:F539-F544
14. Shah SV, Walker PD: Evidence suggesting a role for hydroxyl radical in glycerol-induced acute renal failure. Am J Physiol 1988, 255:F438-F443
15. Zager RA: Combined mannitol and deferoxamine therapy for myohemoglobinuric renal injury and oxidant tubular stress. J Clin Invest 1992, 90:711-719
16. Baliga R, Zhang Z, Baliga M, Shah SV: Evidence for cytochrome p450 as a source of catalytic iron in myoglobinuric acute renal failure. Kidney Int 1996, 49:362-369
17. Johnson WJ, Phillips MC, Rothblatt GH: Lipoproteins and cellular cholesterol homeostasis. Subcellular Biochemistry: Cholesterol: Its Functions and Metabolism in Biology and Medicine. Edited by R Bittman. Plenum Press, New York, 1997, pp 235-276
18. Wang N, Silver DL, Costet P, Tall AR: Specific binding of ApoA-1, enhanced cholesterol efflux, and altered plasma membrane morphology in cell expressing ABC1. J Biol Chem 2002, 275:33053-33058
19. Schmitz G, Langmann T: Structure, function, and regulation of the ABC1 gene product. Curr Opin Lipidol 2001, 12:129-140
20. Fielding CJ, Fielding PE: Cellular cholesterol efflux. Biochim Biophys Acta 2001, 1533:175-189
21. Bortnick AE, Rothblat GH, Stoudt G, Hoppe KL, Royer LJ, McNeish J, Francone OL: The correlation of ATP-binding cassette 1 mRNA levels with cholesterol efflux from various cell lines. J Biol Chem 2000, 275:28634-28640
22. Sparrow CP, Baffic J, Lam MH, Lund EG, Adams AD, Fu X, Hayes N, Jones AB, Macnaul KL, Ondeyka J, Singh S, Wang J, Zhou G, Moller DE, Wright SD, Menke JG: A potent synthetic LXR agonist is more effective than cholesterol loading at inducing ABCA-1 mRNA and stimulating cholesterol efflux. J Biol Chem 2002, 277:10021-10027
23. Jian B, de la Llera-Moya M, Ji Y, Wang N, Phillips MC, Swaney JB, Tall AR, Rothblat GH: Scavenger receptor class B type I as a mediator of cellular cholesterol efflux to lipoproteins and phospholipid acceptors. J Biol Chem 1998, 273:5599-5606
24. Ji Y, Jian B, Wang N, Sun Y, Moya ML, Phillips MC, Rothblat GH, Swaney JB, Tall AR: Scavenger receptor B1 promotes high-density lipoprotein-mediated cellular cholesterol efflux. J Biol Chem 1997, 272:20982-20985
25. Kellner-Weibel G, de la Llera-Moya M, Connelly MA, Stoudt G, Christian AE, Haynes MP, Williams DL, Rothblat GH: Expression of scavenger receptor B1 in COS-7 cells alters cholesterol content and distribution. Biochemistry 2000, 39:221-229
26. de la Llera-Moya M, Rothblat GH, Connelly MA, Kellner-Weibel G, Sakr SW, Phillips MC, Williams DL: Scavenger receptor B1 (SR-B1) mediates free cholesterol flux independently of HDL tethering to the cell surface. J Lipid Research 1999, 40:575-580
27. Acton S, Rigotti A, Landschulz KT, Xy S, Hobbs HH, Krieger M: Identification of scavenger receptor SR-B1 as a high-density lipoprotein receptor. Science 1996, 271:518-520
28. Landschultz KT, Pathak RK, Rigotti A, Krieger M, Hobbs HH: Regulation of scavenger receptor, class B, type 1, a high density lipoprotein receptor, in liver and steroidogneic tissues of the rat. J Clin Invest 1996, 98:984-985
29. Krause BR, Auerbach BJ: Reverse cholesterol transport and future pharmacological approaches to the treatment of atherosclerosis. Curr Opin Invest Drugs 2001, 2:375-381
30. Ryan MJ, Johnson G, Kirk J, Fuerstenberg SM, Zager RA, Torok-Storb B: HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney Int 1994, 45:48-57
31. Johnson ACM, Yabu J, Hanson S, Shah VO, Zager RA: Experimental glomerulopathy alters renal cortical cholesterol, SR-B1, ABCA-1, and HMG CoA reductase expression. Am J Pathol 2003, 162:273-281
32. Fluiter K, van Berkel TJ: Scavenger receptor B1 substrates inhibit the selective uptake of high-density lipoprotein cholesteryl esters by rat parenchymal cells. Biochem J 1997, 326:4515-4519
33. Imachi H, Murao K, Sato M, Hosokawa H, Ishida T, Takahara J: CD36 LIMPIJ analagous-1, a human homolog of the rodent scavenger receptor B1, provides the cholesterol ester for steroidogenesis in adrenocortical cells. Metabolism 1996, 48:627-630
34. Matveev S, van der Westhuyzen DR, Smart EJ: Co-expression of receptor-B1 and caveolin-1 is associated with enhanced selective cholesteryl ester uptake pathway in mice with deletion of the low density lipoprotein receptor function. J Lipid Res 1999, 40:1647-1654
35. Stirewalt DL, Appelbaum FR, Willman CL, Zager RA, Banker DE: Mevastatin can increase toxicity in primary AMLs exposed to standard therapeutic agents, but statin efficacy is not simply associated with RAS hotspot mutations of overexpression. Leukemia Res 2002, 1572:1-13
36. Li HY, Appelbaum FR, Willman CL, Zager RA, Banker DE: Cholesterol modulating agents kill acute myeloid leukemia cells and sensitize them to therapeutics by blocking adaptive cholesterol responses. Blood 2003, 101:3628-3634
37. Baranova J, Vishnyakova T, Bocharov A, Chen Z, Remaley AT, Stonik J, Eggerman TL, Patterson AP: Lipopolysaccharide down-regulates both scavenger receptor B1 and ATP binding cassette transporter A1 in RAW cells. Infect Immun 2002, 70:2995-3003
38. Danesh FR, Sadeghi MM, Amro N, Phillips C, Zeng L, Sahai A, Kanwar YS: 3-hydroxymethylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase / p21 signaling pathway: implications for diabetic nephropathy. Proc Natl Acad Sci USA 2002, 99:8301-8305